BioWorld

Oct. 17, 2016

View Archived Issues

BioWorld stock report for public biotechnology companies

Read More

The week's biggest gainers and losers

Read More

Money raised by biotech: Jan. 1 - Oct. 14, 2016

Read More

Money raised by biotech in 2016 vs. 2015

Read More

Regulatory submissions, approvals & other actions: September 2016

Read More

Phase III clinical trials update: September 2016

Read More

Phase II clinical trials update: September 2016

Read More

Phase I clinical trials update: September 2016

Read More

Cannabinoids medicalized for multiple indications

Marijuana has been used as a medical treatment for centuries. But there’s only one cannabinoid-based drug on the market, Marinol (dronabinol, Abbvie Inc.), which was approved back in 1985. Read More

Week in review

Read More

Week in Washington

Read More

Word on the street

Read More

FDA approvals in September

Read More